Legislative barriers due to national procurement regulations in countries facing transition do not always allow direct public procurement of HIV and malaria medicines via tenders, as the PPM was often the sole procurement channel available, guaranteeing quality, timely deliveries and good pricing. Therefore, national laws must be adapted prior to transitioning and include new provisions allowing public procurement of HIV, TB and malaria products through competitive bids. As the PPM should remain available to transitioned countries through the wambo.org platform, beyond the current piloting, this should however be less of an issue in the future for some countries.
